If we open our borders to anyone who desires to come, if there are no prerequisites to citizenship, we will lose what we call ...

Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial. Shares in the Anglo-US biotech rose sharply after ...

Dena Takruri speaks to Assal Rad about how badly legacy media has failed at one of its most important jobs: covering war ...